Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DCFBC PET in Primary Prostate Cancer
NCT01496157Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of 18F-DCFBC in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: PET Detection of Primary Prostate Cancer at 24 months. Started Sep 2012; status: completed.
02
Drugs
18F-DCFBC
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01496157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01496157.